Innoviva
- Pharmaceutical Preparations
- Burlingame, California
Compensation history
Top executives at Innoviva received an average of $2M per person in annual compensation from 2006 to 2021.
Average pay of disclosed executives at Innoviva
By year
Executives
We found 13 executives who work or worked at Innoviva.
Pavel Raifeld
Innoviva
Chief Executive Officer
Marianne Zhen
Innoviva
Chief Accounting Officer
Geoffrey Hulme
Innoviva
Interim Principal Executive Officer
Michael Aguiar
Innoviva
Chief Executive Officer
Eric d'Esparbes
Innoviva
Chief Financial Officer
George Abercrombie
Innoviva
Former Senior Vice President and Chief Commercial Officer
Theodore Witek
Innoviva
Chief Scientific Officer
Michael Faerm
Innoviva
Senior Vice President and Chief Business Officer
News
Innoviva CEO Pavel Raifeld's 2021 pay falls 35% to $1.3M
March 25, 2022
Innoviva CEO Pavel Raifeld receives $1.9M in 2020
April 2, 2021
Innoviva Interim Principal Executive Officer Geoffrey Hulme's 2019 pay jumps 183% to $856K
March 11, 2020
Innoviva CEO Michael Aguiar's 2018 pay slips 11% to $3.7M
March 13, 2019
About Innoviva
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address1350 Old Bayshore Highway, Suite 400, Burlingame, California 94010
- Phone6502389600
- Fiscal year endDecember 31
- Former names
- THERAVANCE INCUntil December 6, 2015
- ADVANCED MEDICINE INCUntil August 1, 2000
Source: SEC filings on March 25, 2022, April 2, 2021, March 11, 2020, March 13, 2019, March 23, 2018, March 25, 2016, March 24, 2015, April 15, 2014, March 12, 2013, April 16, 2012, March 16, 2011, March 24, 2010, and March 9, 2009.